ZIA CP010152 00030 (ZIA) | |||
---|---|---|---|
Title | PLCO - Ovarian cancer and endometrial cancers | ||
Institution | NCI, Bethesda, MD | ||
Principal Investigator | Wentzensen, Nicolas | NCI Program Director | N/A |
Cancer Activity | N/A | Division | DCEG |
Funded Amount | $145,913 | Project Dates | null - null |
Fiscal Year | 2018 | Project Type | Intramural |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Biochemical Epidemiology (45.0%) Cancer (100.0%) |
Ovarian Cancer (50.0%) Uterine (50.0%) |
||
Research Type | |||
Interactions of Genes and/or Genetic Polymorphisms with Exogenous and/or Endogenous Factors Resources and Infrastructure Related to Detection, Diagnosis, or Prognosis |
|||
Abstract | |||
Women enrolled in the Prostate, Lung, Colon, & Ovarian Cancer screening trial are examined by transvaginal ultrasound, their serum samples are tested for elevated CA-125 levels, and cancers of the ovary and endometrium are reported annually. We examine risk factors (genetic, hormonal, reproductive, anthropometric, and others) and biomarkers (hormones, inflammation markers, and others) for ovarian and endometrial cancer risk and their relationship to ovarian cancer screening. |